234 related articles for article (PubMed ID: 11801767)
1. Gemcitabine, cisplatin, and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study.
Benasso M; Merlano M; Sanguineti G; Corvò R; Numico G; Ricci I; Pallestrini E; Santelli A; Vitale V; Marchetti G; Rosso R
Am J Clin Oncol; 2001 Dec; 24(6):618-22. PubMed ID: 11801767
[TBL] [Abstract][Full Text] [Related]
2. Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck.
Benasso M; Corvò R; Ponzanelli A; Sanguineti G; Ricci I; Pallestrini E; Santelli A; Vitale V; Rosso R
Ann Oncol; 2004 Apr; 15(4):646-52. PubMed ID: 15033674
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of low-dose gemcitabine and radiation alternated to cisplatin and 5-fluorouracil: an active and manageable regimen for stage IV squamous cell carcinoma of the head and neck.
Benasso M; Vigo V; Bacigalupo A; Ponzanelli A; Marcenaro M; Corvò R; Margarino G
Radiother Oncol; 2008 Oct; 89(1):44-50. PubMed ID: 18423671
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.
Numico G; Russi EG; Vitiello R; Sorrentino R; Colantonio I; Cipolat M; Taglianti RV; Pelissero A; Fea E; Granetto C; Di Costanzo G; Gasco M; Garrone O; Occelli M; Merlano M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):731-7. PubMed ID: 17011449
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
6. Alternating chemotherapy: gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer.
Aguilar-Ponce JL; Granados-García M; Cruz López JC; Maldonado-Magos F; Alvarez-Avitia MA; Arrieta O; González-Ramírez I; Lara-Cruz G; Martinez-Juárez I; Medina-Santillan R; Castillo-Hernández C; De la Garza-Salazar J
Oral Oncol; 2013 Mar; 49(3):249-54. PubMed ID: 23043985
[TBL] [Abstract][Full Text] [Related]
7. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer.
Kohno N; Kitahara S; Tamura E; Tanabe T
Oncology; 2002; 63(3):226-31. PubMed ID: 12381901
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
9. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
Milano MT; Haraf DJ; Stenson KM; Witt ME; Eng C; Mittal BB; Argiris A; Pelzer H; Kozloff MF; Vokes EE
Clin Cancer Res; 2004 Aug; 10(15):4922-32. PubMed ID: 15297392
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, 5-fluorouracil, and high-dose folinic acid in patients with advanced unresectable head and neck cancer.
Alba E; Sanchez-Chaparro MA; Alonso L; Ribelles N; Ramon Delgado J; Rueda A; Pablo Tenllado P; Solano J; Urquiza R
Am J Clin Oncol; 1996 Apr; 19(2):140-3. PubMed ID: 8610637
[TBL] [Abstract][Full Text] [Related]
12. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
[TBL] [Abstract][Full Text] [Related]
13. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E
J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374
[TBL] [Abstract][Full Text] [Related]
14. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.
Mizumachi T; Homma A; Kakizaki T; Sakashita T; Kano S; Hatakeyama H; Tsuchiya K; Yasuda K; Onimaru R; Shirato H; Taguchi J; Shimizu Y; Kinoshita I; Akita H; Fukuda S
Int J Clin Oncol; 2015 Jun; 20(3):431-7. PubMed ID: 24993675
[TBL] [Abstract][Full Text] [Related]
16. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S
Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck.
Aguilar-Ponce J; Granados-García M; Villavicencio V; Poitevin-Chacón A; Green D; Dueñas-González A; Herrera-Gómez A; Luna-Ortiz K; Alvarado A; Martínez-Said H; Castillo-Henkel C; Segura-Pacheco B; De la Garza J
Ann Oncol; 2004 Feb; 15(2):301-6. PubMed ID: 14760126
[TBL] [Abstract][Full Text] [Related]
18. Accelerated fractionation radiotherapy and concomitant chemotherapy in patients with stage IV inoperable head and neck cancer.
Dragovic J; Doyle TJ; Tilchen EJ; Nichols RD; Benninger MS; Carlson ER; Boyd SB; Jacobsen GR
Cancer; 1995 Nov; 76(9):1655-61. PubMed ID: 8635071
[TBL] [Abstract][Full Text] [Related]
19. Treatment with cisplatin and fluorouracil alternating with radiation favourably affects prognosis of inoperable squamous cell carcinoma of the head and neck: results of a multivariate analysis on 273 patients.
Benasso M; Bonelli L; Numico G; Corvò R; Sanguineti G; Rosso R; Vitale V; Merlano M
Ann Oncol; 1997 Aug; 8(8):773-9. PubMed ID: 9332685
[TBL] [Abstract][Full Text] [Related]
20. [Concomitant bifractionated radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in locally progressive, non-resectable epidermoid carcinomas of the pharynx: ten years experience at the Antoine Lacassagne center].
Magné N; Pivot X; Marcy PY; Chauvel P; Courdi A; Dassonville O; Poissonnet G; Vallicioni J; Ettore F; Falewee MN; Milano G; Santini J; Lagrange JL; Schneider M; Demard F; Bensadoun RJ
Cancer Radiother; 2001 Aug; 5(4):413-24. PubMed ID: 11521390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
